{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:36:35Z","timestamp":1775478995481,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.antiviral.2022.105407","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T09:32:47Z","timestamp":1663752767000},"page":"105407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses"],"prefix":"10.1016","volume":"207","author":[{"given":"Yuanjun","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feibo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxiang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105407_bib1","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/ncomms6907","article-title":"Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion","volume":"6","author":"Bohm","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105407_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/QCO.0000000000000572","article-title":"Current and new rotavirus vaccines","volume":"32","author":"Burke","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105407_bib3","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/jvi.62.6.2164-2172.1988","article-title":"Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11","volume":"62","author":"Burns","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105407_bib4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1128\/jvi.39.3.879-888.1981","article-title":"Proteolytic enhancement of rotavirus infectivity: molecular mechanisms","volume":"39","author":"Estes","year":"1981","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105407_bib5","article-title":"Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells","volume":"130","author":"Feng","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2022.105407_bib6","doi-asserted-by":"crossref","first-page":"E4997","DOI":"10.1073\/pnas.1316517110","article-title":"Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine","volume":"110","author":"Freed","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2022.105407_bib7","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1128\/JVI.77.18.9969-9978.2003","article-title":"Integrin-using rotaviruses bind alpha 2 beta 1 integrin alpha 2 I domain via VP4 DGE sequence and recognize alpha X beta 2 and alpha V beta 3 by using VP7 during cell entry","volume":"77","author":"Graham","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105407_bib8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jmv.23812","article-title":"Identification of a highly conserved and surface exposed B-cell epitope on the nucleoprotein of influenza A virus","volume":"86","author":"Gui","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2022.105407_bib9","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/JVI.78.7.3325-3332.2004","article-title":"Isolation of human monoclonal antibodies that neutralize human rotavirus","volume":"78","author":"Higo-Moriguchi","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105407_bib10","series-title":"The Rotavirus Vaccine Development Pipeline","author":"Kirkwood","year":"2017"},{"key":"10.1016\/j.antiviral.2022.105407_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.coviro.2013.05.010","article-title":"Advances in structure-based vaccine design","volume":"3","author":"Kulp","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2022.105407_bib12","doi-asserted-by":"crossref","unstructured":"Lanata, C.F., Fischer-Walker, C.L., Olascoaga, A.C., Torres, C.X., Aryee, M.J., Black, R.E., Child Health Epidemiology Reference Group of the World Health, O., Unicef, 2013. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One 8, e72788.","DOI":"10.1371\/journal.pone.0072788"},{"key":"10.1016\/j.antiviral.2022.105407_bib13","series-title":"Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production","author":"Li","year":"2022"},{"key":"10.1016\/j.antiviral.2022.105407_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2014.08.012","article-title":"Development of an enzyme-linked immunospot assay for determination of rotavirus infectivity","volume":"209","author":"Li","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2022.105407_bib15","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.vaccine.2018.03.011","article-title":"Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine","volume":"36","author":"Li","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2022.105407_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00547-18","article-title":"Structural basis for the broad, antibody-mediated neutralization of H5N1 influenza virus","volume":"92","author":"Lin","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105407_bib17","article-title":"Binding patterns of rotavirus genotypes P 4 , P 6 , and P 8 in China with histo-blood group Antigens","volume":"10","author":"Ma","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105407_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam5434","article-title":"VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans","volume":"9","author":"Nair","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105407_bib19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/jcm.30.6.1392-1397.1992","article-title":"Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus","volume":"30","author":"Padilla-Noriega","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105407_bib20","article-title":"Comparative analysis of G1P[8] rotaviruses identified prior to vaccine implementation in Pakistan with Rotarix and RotaTeq vaccine strains","volume":"11","author":"Sadiq","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2022.105407_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0042-6822(86)90205-9","article-title":"Antigenic mapping of the surface proteins of rhesus rotavirus","volume":"155","author":"Shaw","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2022.105407_bib22","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1128\/jvi.62.7.2421-2426.1988","article-title":"Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus","volume":"62","author":"Taniguchi","year":"1988","journal-title":"J. Virol."},{"issue":"Pt 5","key":"10.1016\/j.antiviral.2022.105407_bib23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1099\/0022-1317-66-5-1045","article-title":"Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses","volume":"66","author":"Taniguchi","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2022.105407_bib24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.antiviral.2022.105407_bib25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2022.105407_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008386","article-title":"Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens","volume":"16","author":"Xu","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105407_bib27","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.vaccine.2015.03.068","article-title":"Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate","volume":"33","author":"Xue","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2022.105407_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/22221751.2020.1742076","article-title":"Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus","volume":"9","author":"Yang","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2022.105407_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.antiviral.2015.09.010","article-title":"Modeling rotavirus infection and antiviral therapy using primary intestinal organoids","volume":"123","author":"Yin","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105407_bib30","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1016\/j.vaccine.2018.09.035","article-title":"Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2022.105407_bib31","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2004.11.065","article-title":"Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein","volume":"23","author":"Zhang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2022.105407_bib32","doi-asserted-by":"crossref","first-page":"19910","DOI":"10.1074\/jbc.M115.649764","article-title":"A comprehensive study of neutralizing antigenic sites on the hepatitis E virus (HEV) capsid by constructing, clustering, and characterizing a tool box","volume":"290","author":"Zhao","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2022.105407_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1743-422X-9-52","article-title":"Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity","volume":"9","author":"Zhao","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2022.105407_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00535-012-0701-1","article-title":"Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy","volume":"48","author":"Zhao","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2022.105407_bib35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00705-019-04218-9","article-title":"Development and application of a monoclonal-antibody-based blocking ELISA for detection of Japanese encephalitis virus NS1 antibodies in swine","volume":"164","author":"Zhou","year":"2019","journal-title":"Arch. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222001760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222001760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:36:33Z","timestamp":1759062993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354222001760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"alternative-id":["S0166354222001760"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105407","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105407"}}